Elicio Therapeutics
D

ELTX

1.51000
USD
0.11
(7.47%)
Market Closed
Last updated: · Delayed 15 min
Volume
58,648
EPS
-2
Div Yield
-
P/E
-1
Market Cap
40,907,692
Overview
Related Instruments
ACIU
D
AC Immune SA
2.23000
0.12000(5.69%)
AMD
AMD
D
Advanced Micro Devices
449.03
46.51(11.55%)
447.99-1.04(-0.23%)
AUPH
D
Aurinia Pharmaceuticals
16.465
0.260(1.60%)
INTC
INTC
D
Intel
56.280
4.160(7.98%)
56.710+0.430(+0.76%)
NNDM
D
Nano Dimension
1.32500
0.07500(6.00%)
NVAX
D
Novavax
10.775
1.005(10.29%)
10.675-0.100(-0.93%)
NVDA
NVDA
D
NVIDIA
186.680
5.080(2.80%)
188.660+1.980(+1.06%)
PLUG
D
Plug Power
1.45500
0.11000(8.18%)
1.46000+0.00500(+0.34%)
SNDL
D
SNDL
1.41500
0.03500(2.54%)
More

Title: Elicio Therapeutics

Sector: Healthcare
Industry: Biotechnology
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Common questions about Elicio Therapeutics stock

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.